This cartoon tells the story of the MA Paradox—where patients turn against the very industry working to develop life-saving treatments.

This cartoon depicts the home mortgage analogy for drug innovation and the global free-ride on Americans funding the system.

This cartoon compares chemo copays to firefighter copays, showcasing the absurdity of paying drug copays after paying premiums.

US biotech innovators and investors value FDA prioritizing the recruitment and retention of clinical, scientific and regulatory specialists who offer innovators the benefit of experienced, case-specific guidance and problem-solving. This institutional expertise is especially important to small, early-stage, and pre-commercial US biopharma entrepreneurs, who account for the majority of new drug and biologic applications submitted to the FDA.

I know my insurance company’s hold music by heart.

My doctor says I need this. I’ve been paying my premiums. I don’t understand the problem.

So your insurance company decided they know medicine better than your actual doctor?

This Issue Brief presents new data showing that, despite increased federal subsidies and enrollment since 2022, many ACA exchange plans have raised OOP drug costs—undermining the law’s core promise of affordable care.

Our modern world needs a modern FDA with the capacity to accelerate access to safe, effective treatments while sustaining U.S. leadership in biotechnology. PDUFA VIII offers a historic opportunity to make the drug review program faster, more consistent, and more transparent by prioritizing core review activities, modernizing processes, strengthening accountability, and embracing patient-centered science.

Over 250,000 Americans, including children, are living with muscular dystrophies, a group of genetic disorders that causes their muscles to grow weaker.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Nearly 60 million Americans, including millions of children, struggle with a mental illness.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Each year, over 80,000 American adults and children are diagnosed with lymphoma, a cancer of the immune system.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Nearly 7 million Americans are living with dementia, a group of progressive brain disorders that affect memory, thinking, and the ability to do everyday things.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

More than 1 million Americans are blind, and more than 12 million Americans are losing their vision.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 6 million Americans are living with Alzheimer's disease, the most common form of dementia.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 65,000 Americans are diagnosed with pancreatic cancer every year.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Nearly 1.5 million older Americans have lost or are losing their vision from wet age-related macular degeneration, also known as wet AMD.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 50,000 Americans, including children, live with some form of myositis.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.